Thomas LeBon

856 total citations
19 papers, 702 citations indexed

About

Thomas LeBon is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Thomas LeBon has authored 19 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Genetics. Recurrent topics in Thomas LeBon's work include Growth Hormone and Insulin-like Growth Factors (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Pluripotent Stem Cells Research (2 papers). Thomas LeBon is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Pluripotent Stem Cells Research (2 papers). Thomas LeBon collaborates with scholars based in United States, Japan and Italy. Thomas LeBon's co-authors include Stephen J. Forman, Yoko Fujita‐Yamaguchi, Jian Jian Li, Daniel Tamae, Tieli Wang, Chu-Chih Shih, Иван Тодоров, Dongchang Zhao, Chia-Lei Lin and Chunyan Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Thomas LeBon

19 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas LeBon United States 13 363 174 140 112 84 19 702
PETER G. H. BYFIELD United Kingdom 13 875 2.4× 128 0.7× 141 1.0× 125 1.1× 143 1.7× 21 1.2k
Reinhard Bolli Switzerland 18 492 1.4× 124 0.7× 61 0.4× 109 1.0× 89 1.1× 34 890
Salvatore F. Pietromonaco United States 9 538 1.5× 150 0.9× 38 0.3× 76 0.7× 62 0.7× 11 1.0k
Angela Russo United States 20 537 1.5× 106 0.6× 89 0.6× 151 1.3× 37 0.4× 38 1.0k
Gaetano Salvatore Italy 21 528 1.5× 134 0.8× 174 1.2× 35 0.3× 113 1.3× 34 1.1k
M López-Barahona Spain 13 492 1.4× 122 0.7× 77 0.6× 22 0.2× 60 0.7× 17 719
Omar Benzakour United Kingdom 15 382 1.1× 177 1.0× 26 0.2× 141 1.3× 80 1.0× 33 869
Daniela Brodbeck Switzerland 7 762 2.1× 110 0.6× 45 0.3× 29 0.3× 71 0.8× 10 989
Gabriela Schneider United States 23 729 2.0× 189 1.1× 40 0.3× 123 1.1× 75 0.9× 55 1.1k
Clare M. Heyworth United Kingdom 19 776 2.1× 331 1.9× 56 0.4× 358 3.2× 96 1.1× 35 1.3k

Countries citing papers authored by Thomas LeBon

Since Specialization
Citations

This map shows the geographic impact of Thomas LeBon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas LeBon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas LeBon more than expected).

Fields of papers citing papers by Thomas LeBon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas LeBon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas LeBon. The network helps show where Thomas LeBon may publish in the future.

Co-authorship network of co-authors of Thomas LeBon

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas LeBon. A scholar is included among the top collaborators of Thomas LeBon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas LeBon. Thomas LeBon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yi, Tangsheng, Dongchang Zhao, Chia-Lei Lin, et al.. (2008). Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood. 112(5). 2101–2110. 173 indexed citations
2.
Wang, Tieli, Daniel Tamae, Thomas LeBon, et al.. (2005). The Role of Peroxiredoxin II in Radiation-Resistant MCF-7 Breast Cancer Cells. Cancer Research. 65(22). 10338–10346. 88 indexed citations
3.
Ozeki, Munetaka, Daniel Tamae, De‐Xing Hou, et al.. (2004). Response of cyclin B1 to ionizing radiation: regulation by NF-kappaB and mitochondrial antioxidant enzyme MnSOD.. PubMed. 24(5A). 2657–63. 37 indexed citations
4.
Shih, Chu-Chih, David DiGiusto, Adam N. Mamelak, Thomas LeBon, & Stephen J. Forman. (2002). Hematopoietic Potential of Neural Stem Cells: Plasticity Versus Heterogeneity. Leukemia & lymphoma. 43(12). 2263–2268. 5 indexed citations
5.
Shih, Chu-Chih, Yehua Weng, Adam N. Mamelak, et al.. (2001). Identification of a candidate human neurohematopoietic stem-cell population. Blood. 98(8). 2412–2422. 93 indexed citations
6.
Shih, Chu-Chih, Jun Hu, Daniel A. Arber, Thomas LeBon, & Stephen J. Forman. (2000). Transplantation and growth characteristics of human fetal lymph node in immunodeficient mice. Experimental Hematology. 28(9). 1046–1053. 6 indexed citations
7.
Gacad, Mercedes A., Hong Chen, Jonathan Eli Arbelle, Thomas LeBon, & John S. Adams. (1997). Functional Characterization and Purification of an Intracellular Vitamin D-binding Protein in Vitamin D-resistant New World Primate Cells. Journal of Biological Chemistry. 272(13). 8433–8440. 44 indexed citations
8.
Giannini, Stefano, S. Mohan, Junko Kasuya, et al.. (1994). Characterization of insulin-like growth factor-binding proteins produced by cultured fibroblasts from patients with noninsulin-dependent diabetes mellitus, insulin-dependent diabetes mellitus, or obesity.. The Journal of Clinical Endocrinology & Metabolism. 79(6). 1824–1830. 12 indexed citations
9.
LeBon, Thomas, Junko Kasuya, Raymond J. Paxton, et al.. (1992). Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions.. Endocrinology. 130(6). 3265–3274. 10 indexed citations
10.
Pezzino, V., Giovanni Milazzo, Lucia Frittitta, et al.. (1991). Radioimmunoassay for human insulin-like growth factor-I receptor: Applicability to breast carcinoma specimens and cell lines. Metabolism. 40(8). 861–865. 8 indexed citations
11.
Perdue, James F., Thomas LeBon, Jun Kato, Brian Hampton, & Yoko Fujita‐Yamaguchi. (1991). Binding Specificities and Transducing Function of the Different Molecular Weight Forms of Insulin-Like Growth Factor-II (IGF-II) on IGF-I Receptors*. Endocrinology. 129(6). 3101–3108. 34 indexed citations
12.
13.
14.
Tappy, Luc, Yoko Fujita‐Yamaguchi, Thomas LeBon, & Guenther Boden. (1988). Antibodies to Insulin-Like Growth Factor I Receptors in Diabetes and Other Disorders. Diabetes. 37(12). 1708–1714. 17 indexed citations
15.
Fujita‐Yamaguchi, Yoko, Thomas LeBon, Makoto Tsubokawa, et al.. (1986). Comparison of insulin-like growth factor I receptor and insulin receptor purified from human placental membranes.. Journal of Biological Chemistry. 261(35). 16727–16731. 33 indexed citations
16.
LeBon, Thomas, Steven Jacobs, Pedro Cuatrecasas, S. P. Kathuria, & Yoko Fujita‐Yamaguchi. (1986). Purification of insulin-like growth factor I receptor from human placental membranes.. Journal of Biological Chemistry. 261(17). 7685–7689. 44 indexed citations
17.
LeBon, Thomas, et al.. (1985). Asymmetric [14C]albumin transport across bullfrog alveolar epithelium. Journal of Applied Physiology. 59(4). 1290–1297. 35 indexed citations
18.
LeBon, Thomas, et al.. (1984). Effects of ultraviolet light on the in vitro assembly of microtubules. Biochemistry. 23(6). 1073–1080. 29 indexed citations
19.
LeBon, Thomas, et al.. (1977). The kinetics of oxidation of a trifluoroacetylated derivative of cytochrome C by ferricyanide. Biochemical and Biophysical Research Communications. 76(3). 746–750. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by PETER G. H. BYFIELD Breakdown of academic impact, for papers by Reinhard Bolli Breakdown of academic impact, for papers by Salvatore F. Pietromonaco Breakdown of academic impact, for papers by Angela Russo Breakdown of academic impact, for papers by Gaetano Salvatore Breakdown of academic impact, for papers by M López-Barahona Breakdown of academic impact, for papers by Omar Benzakour Breakdown of academic impact, for papers by Daniela Brodbeck Breakdown of academic impact, for papers by Gabriela Schneider Breakdown of academic impact, for papers by Clare M. Heyworth
Rankless by CCL
2026